Bm. Bakker et al., Metabolic control analysis of glycolysis in trypanosomes as an approach toimprove selectivity and effectiveness of drugs, MOL BIOCH P, 106(1), 2000, pp. 1-10
Glycolysis is the only ATP-generating process in bloodstream form trypanoso
mes and is therefore a promising drug target. Inhibitors which decrease sig
nificantly the glycolytic flux will kill the parasites. Both computer simul
ation and experimental studies of glycolysis in bloodstream form Trypanosom
a brucei indicated that the control of the glycolytic flux is shared by sev
eral steps in the pathway. The results of these analyses provide quantitati
ve information about the prospects of decreasing the flux by inhibition of
any individual enzyme. The plasma membrane glucose transporter appears the
most promising target from this perspective, followed by aldolase, glyceral
dehyde-3-phosphate dehydrogenase, phosphoglycerate kinase and glycerol-3-ph
osphate dehydrogenase. Non-competitive or irreversible inhibitors would be
most effective. but it is argued that potent competitive inhibitors can be
suitable, provided that the concentration of the competing substrate cannot
increase unrestrictedly. Such is the case for inhibitors that compete with
coenzymes or with blood glucose. (C) 2000 Elsevier Science B.V. All rights
reserved.